12 April 2024
12 April 2024
The upcoming Clinical Trials In Oncology West Coast 2024 will bring together pharma and biotech experts to discuss clinical-stage cancer therapy development.
Ajovy is already approved in the US and Europe, with estimated global sales of $773m by 2030.
CEO of Lipocine, Dr Mahesh Patel said the company will be meeting with the FDA to discuss future plans for the candidate.
The $9m French funding is for the registration Phase III trial for OSE’s Tedopi as a second-line treatment for non-small cell lung cancer (NSCLC).
The clinical trial of the Lumerah system is set to begin in April 2024 in Norfolk, Virginia, under FDA IDE.
In the trial, ATX101 was well tolerated with its safety profile generally comparable to that of bupivacaine.
Allocetra demonstrated to possess an acceptable safety and tolerability profile versus placebo in the trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
